1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 76, 2025
  5. Article

Annual Review of Medicine

Volume 76, 2025

Contemporary Management of Acute Ischemic Stroke

Abstract

In the past decade, adding mechanical thrombectomy (MT) of intracranial arterial occlusions to intravenous (IV) thrombolysis has revolutionized the treatment of acute ischemic stroke (AIS) by expanding the therapeutic window to 24 h. Treatment decisions require establishing a high probability of AIS; confirming time since last known well (LKW); assessing severity of the neurological deficit; determining any contraindications to IV thrombolysis; and performing neuroimaging, usually noncontrast computed tomography (NCCT), to exclude intracerebral hemorrhage. If time since LKW is less than 4.5 h, patients with disabling stroke without contraindications can proceed immediately to IV thrombolysis while the decision about MT is under way. For some patients, the MT decision can be made on the basis of clinical assessment, NCCT, and CT angiography showing a large vessel occlusion. Others may require additional neuroimaging. Patients who are not candidates for IV thrombolysis within 4.5 h or MT should be immediately evaluated for eligibility for extended-window IV thrombolysis or early antiplatelet treatment.

Keyword(s): acute ischemic stroke, acute stroke treatment, antithrombotic treatment, endovascular treatment, thrombectomy, thrombolysis
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-050823-094312
2025-01-27
2025-05-01
Loading full text...

Full text loading...

/deliver/fulltext/med/76/1/annurev-med-050823-094312.html?itemId=/content/journals/10.1146/annurev-med-050823-094312&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Saposnik G, Bushnell C, Coutinho JM, et al. 2024.. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. . Stroke 55::e77–90
     [Google Scholar]
  2. 2.
    Ferriero DM, Fullerton HJ, Bernard TJ, et al. 2019.. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. . Stroke 50::e51–96
     [Google Scholar]
  3. 3.
    Runchey S, McGee S. 2010.. Does this patient have a hemorrhagic stroke? Clinical findings distinguishing hemorrhagic stroke from ischemic stroke. . JAMA 303::2280–86
     [Google Scholar]
  4. 4.
    Powers WJ, Rabinstein AA, Ackerson T, et al. 2019.. Guidelines for the early management of patients with acute ischemic stroke. 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. . Stroke 50::e344–418
     [Google Scholar]
  5. 5.
    Hwang DY, Silva GS, Furie KL, Greer DM. 2012.. Comparative sensitivity of computed tomography versus magnetic resonance imaging for detecting acute posterior fossa infarct. . J. Emerg. Med. 42::559–65
     [Google Scholar]
  6. 6.
    Lyden P, Brott T, Tilley B, et al. 1994.. Improved reliability of the NIH Stroke Scale using video training. . Stroke 25::2220–26
     [Google Scholar]
  7. 7.
    Barber PA, Demchuk AM, Zhang J, Buchan AM. 2000.. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. . Lancet 355::1670–74
     [Google Scholar]
  8. 8.
    Nogueira RG, Jadhav AP, Haussen DC, et al. 2018.. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. . N. Engl. J. Med. 378::11–21
     [Google Scholar]
  9. 9.
    Albers GW, Marks MP, Kemp S, et al. 2018.. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. . N. Engl. J. Med. 378::708–18
     [Google Scholar]
  10. 10.
    Broderick JP, Adeoye O, Elm J. 2017.. Evolution of the modified Rankin Scale and its use in future stroke trials. . Stroke 48::2007–12
     [Google Scholar]
  11. 11.
    Lees KR, Bluhmki E, von Kummer R, et al. 2010.. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. . Lancet 375::1695–703
     [Google Scholar]
  12. 12.
    Khatri P, Kleindorfer DO, Devlin T, et al. 2018.. Effect of alteplase versus aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. . JAMA 320::156–66
     [Google Scholar]
  13. 13.
    Chen HS, Cui Y, Zhou ZH, et al. 2023.. Dual antiplatelet therapy versus alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial. . JAMA 329::2135–44
     [Google Scholar]
  14. 14.
    Whiteley WN, Emberson J, Lees KR, et al. 2016.. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. . Lancet Neurol. 15::925–33
     [Google Scholar]
  15. 15.
    Emberson J, Lees KR, Lyden P, et al. 2014.. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. . Lancet 384::1929–35
     [Google Scholar]
  16. 16.
    Kvistad CE, Novotny V, Naess H, et al. 2019.. Safety and predictors of stroke mimics in the Norwegian Tenecteplase Stroke Trial (NOR-TEST). . Int. J. Stroke 14::508–16
     [Google Scholar]
  17. 17.
    Heran M, Lindsay P, Gubitz G, et al. 2022.. Canadian stroke best practice recommendations: acute stroke management, 7th edition Practice Guidelines Update, 2022. . Can. J. Neurol. Sci. 51::1–31
     [Google Scholar]
  18. 18.
    Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. 2016.. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. . Stroke 47::581–641
     [Google Scholar]
  19. 19.
    Tsai TY, Liu YC, Huang WT, et al. 2024.. Risk of bleeding following non–vitamin K antagonist oral anticoagulant use in patients with acute ischemic stroke treated with alteplase. . JAMA Intern. Med. 184::37–45
     [Google Scholar]
  20. 20.
    Berge E, Whiteley W, Audebert H, et al. 2021.. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. . Eur. Stroke J. 6::1–62
     [Google Scholar]
  21. 21.
    Meinel TR, Wilson D, Gensicke H, et al. 2023.. Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants. . JAMA Neurol. 80::233–43
     [Google Scholar]
  22. 22.
    Reish NJ, Jamshidi P, Stamm B, et al. 2023.. Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke. . N. Engl. J. Med. 388::478–79
     [Google Scholar]
  23. 23.
    Cummings J, Apostolova L, Rabinovici GD, et al. 2023.. Lecanemab: appropriate use recommendations. . J. Prev. Alzheimer's Dis. 10::362–77
     [Google Scholar]
  24. 24.
    Natl. Inst. Neurol. Disord. Stroke rt-PA Stroke Study Group. 1995.. Tissue plasminogen activator for acute ischemic stroke. . N. Engl. J. Med. 333::1581–87
     [Google Scholar]
  25. 25.
    Anderson CS, Huang Y, Lindley RI, et al. 2019.. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. . Lancet 393::877–88
     [Google Scholar]
  26. 26.
    Thomalla G, Simonsen CZ, Boutitie F, et al. 2018.. MRI-guided thrombolysis for stroke with unknown time of onset. . N. Engl. J. Med. 379::611–22
     [Google Scholar]
  27. 27.
    Campbell BCV, Ma H, Ringleb PA, et al. 2019.. Extending thrombolysis to 4.5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. . Lancet 394::139–47
     [Google Scholar]
  28. 28.
    Wang Y, Li S, Pan Y, et al. 2023.. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. . Lancet 401::645–54
     [Google Scholar]
  29. 29.
    Menon BK, Buck BH, Singh N, et al. 2022.. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. . Lancet 400::161–69
     [Google Scholar]
  30. 30.
    Alamowitch S, Turc G, Palaiodimou L, et al. 2023.. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. . Eur. Stroke J. 8::8–54
     [Google Scholar]
  31. 31.
    Majoie CB, Cavalcante F, Gralla J, et al. 2023.. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials. . Lancet 402::965–74
     [Google Scholar]
  32. 32.
    Turc G, Tsivgoulis G, Audebert HJ, et al. 2022.. European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. . J. Neurointerv. Surg. 14::209–27
     [Google Scholar]
  33. 33.
    Powers WJ. 2020.. Acute ischemic stroke. . N. Engl. J. Med. 383::252–60
     [Google Scholar]
  34. 34.
    Berkhemer OA, Fransen PS, Beumer D, et al. 2015.. A randomized trial of intraarterial treatment for acute ischemic stroke. . N. Engl. J. Med. 372::11–20
     [Google Scholar]
  35. 35.
    Powers WJ, Derdeyn CP, Biller J, et al. 2015.. American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. . Stroke 46::3020–35
     [Google Scholar]
  36. 36.
    Saver JL, Goyal M, van der Lugt A, et al. 2016.. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. . JAMA 316::1279–88
     [Google Scholar]
  37. 37.
    Huo X, Ma G, Tong X, et al. 2023.. Trial of endovascular therapy for acute ischemic stroke with large infarct. . N. Engl. J. Med. 388::1272–83
     [Google Scholar]
  38. 38.
    Sarraj A, Hassan AE, Abraham MG, et al. 2023.. Trial of endovascular thrombectomy for large ischemic strokes. . N. Engl. J. Med. 388::1259–71
     [Google Scholar]
  39. 39.
    Bendszus M, Fiehler J, Subtil F, et al. 2023.. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. . Lancet 402::1753–63
     [Google Scholar]
  40. 40.
    Costalat V, Jovin TG, Albucher JF, et al. 2024.. Trial of thrombectomy for stroke with a large infarct of unrestricted size. . N. Engl. J. Med. 390::1677–89
     [Google Scholar]
  41. 41.
    Tao C, Nogueira RG, Zhu Y, et al. 2022.. Trial of endovascular treatment of acute basilar-artery occlusion. . N. Engl. J. Med. 387::1361–72
     [Google Scholar]
  42. 42.
    Jovin TG, Li C, Wu L, et al. 2022.. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. . N. Engl. J. Med. 387::1373–84
     [Google Scholar]
  43. 43.
    Puetz V, Sylaja PN, Coutts SB, et al. 2008.. Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. . Stroke 39::2485–90
     [Google Scholar]
  44. 44.
    Yang P, Song L, Zhang Y, et al. 2022.. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial. . Lancet 400::1585–96
     [Google Scholar]
  45. 45.
    Nam HS, Kim YD, Heo J, et al. 2023.. Intensive versus conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke: the OPTIMAL-BP randomized clinical trial. . JAMA 330::832–42
     [Google Scholar]
  46. 46.
    Chen ZM, Sandercock P, Pan HC, et al. 2000.. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. . Stroke 31::1240–49
     [Google Scholar]
  47. 47.
    Wang Y, Pan Y, Zhao X, et al. 2015.. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes. . Circulation 132::40–46
     [Google Scholar]
  48. 48.
    Johnston SC, Amarenco P, Denison H, et al. 2020.. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. . N. Engl. J. Med. 383::207–17
     [Google Scholar]
  49. 49.
    Johnston SC, Easton JD, Farrant M, et al. 2018.. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. . N. Engl. J. Med. 379::215–25
     [Google Scholar]
  50. 50.
    Gao Y, Chen W, Pan Y, et al. 2023.. Dual antiplatelet treatment up to 72 hours after ischemic stroke. . N. Engl. J. Med. 389::2413–24
     [Google Scholar]
  51. 51.
    Sandercock PA, Counsell C, Kane EJ. 2015.. Anticoagulants for acute ischaemic stroke. . Cochrane Database Syst. Rev. 3::CD000024
     [Google Scholar]
  52. 52.
    Saxena R, Lewis S, Berge E, et al. 2001.. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. . Stroke 32::2333–37
     [Google Scholar]
  53. 53.
    Whiteley WN, Adams HP Jr., Bath PM, et al. 2013.. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. . Lancet Neurol. 12::539–45
     [Google Scholar]
  54. 54.
    Eur. Atr. Fibrillation Trial (EAFT) Study Group. 1993.. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. . Lancet 342::1255–62
     [Google Scholar]
  55. 55.
    Joglar JA, Chung MK, Armbruster AL, et al. 2024.. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. . Circulation. 149::e1–156. Correction . 2024.. Circulation. 149::e167. Correction . 2024.. Circulation. 149::e936. Correction . 2024.. Circulation 149::e1413
     [Google Scholar]
  56. 56.
    Van Gelder IC, Rienstra M, Bunting KV, et al. 2024.. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). . Eur. Heart J. 45::3314–414
     [Google Scholar]
  57. 57.
    Fischer U, Koga M, Strbian D, et al. 2023.. Early versus later anticoagulation for stroke with atrial fibrillation. . N. Engl. J. Med. 388::2411–21
     [Google Scholar]
  58. 58.
    Oldgren J, Asberg S, Hijazi Z, et al. 2022.. Early versus delayed non–vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. . Circulation 146::1056–66
     [Google Scholar]
  59. 59.
    Strandgaard S. 1976.. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. . Circulation 53::720–27
     [Google Scholar]
  60. 60.
    Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021.. Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. . Stroke 52::e364–467
     [Google Scholar]
  61. 61.
    Dower A, Mulcahy M, Maharaj M, et al. 2022.. Surgical decompression for malignant cerebral oedema after ischaemic stroke. . Cochrane Database Syst. Rev. 11::CD014989
     [Google Scholar]
  62. 62.
    Adeoye O, Nyström KV, Yavagal DR, et al. 2019.. Recommendations for the establishment of stroke systems of care: a 2019 update. . Stroke 50::e187–210
     [Google Scholar]
  63. 63.
    Turc G, Hadziahmetovic M, Walter S, et al. 2022.. Comparison of mobile stroke unit with usual care for acute ischemic stroke management: a systematic review and meta-analysis. . JAMA Neurol. 79::281–90
     [Google Scholar]
  64. 64.
    Kim J, Easton D, Zhao H, et al. 2021.. Economic evaluation of the Melbourne Mobile Stroke Unit. . Int. J. Stroke 16::466–75
     [Google Scholar]
  65. 65.
    Powers W. 2023.. Selecting stroke patients for thrombectomy: Is CTA+ASPECTS enough?. J. Neurol. Neurosurg. Psychiatry 94::779–80
     [Google Scholar]
/content/journals/10.1146/annurev-med-050823-094312
Loading
Contemporary Management of Acute Ischemic Stroke
Annual Review of Medicine 76, 417 (2025); https://doi.org/10.1146/annurev-med-050823-094312
/content/journals/10.1146/annurev-med-050823-094312
/content/journals/10.1146/annurev-med-050823-094312
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error